Koldo Berganzo

Bilbao, PV, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.

Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.

Journal: Neurology

Published: April 29, 2021

Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases.

Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases.

Journal: Neurologia

Published: December 02, 2020

Pandysautonomia and alpha-1 adrenergic receptor autoantibodies: a cause or a consequence? A case report.

Pandysautonomia and alpha-1 adrenergic receptor autoantibodies: a cause or a consequence? A case report.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society

Published: May 13, 2020

Anti-IgLON5 Disease Responsive to Immunotherapy: A Case Report with an Abnormal MRI.

Anti-IgLON5 Disease Responsive to Immunotherapy: A Case Report with an Abnormal MRI.

Journal: Movement disorders clinical practice

Published: April 30, 2018

Seronegative and seropositive autoimmune autonomic ganglionopathy (AAG): Same clinical picture, same response to immunotherapy.

Seronegative and seropositive autoimmune autonomic ganglionopathy (AAG): Same clinical picture, same response to immunotherapy.

Journal: Journal of neuroimmunology

Published: February 25, 2018

Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.

Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.

Journal: Journal of neurology

Published: September 27, 2015

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.

Journal: Parkinsonism & related disorders

Published: October 08, 2014

Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene.

Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene.

Journal: Parkinsonism & related disorders

Published: September 08, 2014

Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension.

Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension.

Journal: Journal of human hypertension

Published: July 30, 2014

Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?

Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: July 28, 2014

Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups.

Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups.

Journal: Neurologia (Barcelona, Spain)

Published: June 07, 2014

Impulse control and repetitive behaviors in Parkinson's disease - are there differences in the relation to dopamine agonist treatment?

Impulse control and repetitive behaviors in Parkinson's disease - are there differences in the relation to dopamine agonist treatment?

Journal: Journal of the neurological sciences

Published: August 29, 2013

Showing 1-12 of 19

Last Updated: 09/26/2026